Sfoglia per Autore
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002 Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P.
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine
2004 DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
2004 CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANNI C; NANNI P.; LOLLINI P-L
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
2004 Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F.
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent
2004 NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO E; MUSIANI P; FORNI G; LOLLINI P-L
Immunological prevention of a multigene cancer syndrome
2004 CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORNI G; NANNI P.; LOLLINI P-L
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
2004 QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S.; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F.
New target antigens for cancer immunoprevention
2005 Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P.
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
2005 Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA.
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
2005 Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA.
Cancer immunoprevention
2005 P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
2005 Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL.
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role.
2006 A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. Lollini; L. Landuzzi; P. Nanni
Cancer biology, what we know and what we don't know.
2006 P. Nanni; C. De Giovanni; P.-L. Lollini
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells
2007 S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Giovanni.
Gene expression profiling differences between synchronous and metachronous metastases of colorectal cancer.
2007 Pantaleo MA; Astolfi A; Nannini M; Ercolani G; Brandi G; Fanello S; Formica S; De Giovanni C; Lollini PL; Pession A; Pinna AD; Biasco G
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
2007 C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. Iezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani.
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
2007 S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. Lollini.
Antimetastatic activity of a preventive cancer vaccine.
2007 P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S. Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells | Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P....-L.; De Giovanni C.; Landuzzi L.; Picci P. | 2002-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine | DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M...; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells | CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANN...I C; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. | Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M...; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent | NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO ...E; MUSIANI P; FORNI G; LOLLINI P-L | 2004-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Immunological prevention of a multigene cancer syndrome | CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORN...I G; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. | QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S....; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F. | 2004-01-01 | THE JOURNAL OF CLINICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| New target antigens for cancer immunoprevention | Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P. | 2005-01-01 | CURRENT CANCER DRUG TARGETS | - | 1.01 Articolo in rivista | - |
| A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. | Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani... P; Forni G; Calogero RA. | 2005-01-01 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario. | Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; ...Cavallo F; Calogero RA. | 2005-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Cancer immunoprevention | P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni | 2005-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. | Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musi...ani P; Cavallo F; Forni G; Nanni P; Lollini PL. | 2005-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. | A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. L...ollini; L. Landuzzi; P. Nanni | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Cancer biology, what we know and what we don't know. | P. Nanni; C. De Giovanni; P.-L. Lollini | 2006-01-01 | - | Bononia University Press | 2.01 Capitolo / saggio in libro | - |
| Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells | S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Gio...vanni. | 2007-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
| Gene expression profiling differences between synchronous and metachronous metastases of colorectal cancer. | Pantaleo MA; Astolfi A; Nannini M; Ercolani G; Brandi G; Fanello S; Formica S; De Giovanni C; Lol...lini PL; Pession A; Pinna AD; Biasco G | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. | C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. I...ezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani. | 2007-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. | S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. L...ollini. | 2007-01-01 | PATHOLOGY ONCOLOGY RESEARCH | - | 1.01 Articolo in rivista | - |
| Antimetastatic activity of a preventive cancer vaccine. | P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S.... Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile